Sadly still hasnt seen enough interest from Insto's nor a Pharma that sees this as a perfect T/O opportunity with huge upside. The SP is still languishing at spec prices. I do hope our fortunes turn around soon but it seems no matter how much potential this has, it still hasn't turned these drugs into a tangible source of income and we are still awaiting much needed data that I pray comes this year as promised by the company. GLTAH.
Ann: Immutep enters into collaboration with CYTLIMIC, page-5
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.010(3.51%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 29.0¢ | $218.0K | 745.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 264849 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 161520 | 12 |
View Market Depth
| Last trade - 10.58am 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
